• Svenska
  • English
Toleranzia - Logotype
  • Start
  • About us
    • Operations
    • Board of Directors
    • Management
    • Team
    • Collaboration
    • Career
  • Technology
    • Tolerogens
  • Program
    • Autoimmune disease
    • Rare disease
    • Myasthenia Gravis
    • SME Instrument
    • Pipeline
  • News
    • All press releases
    • Events
    • Media
  • Investors
    • Rights Issue 2023
    • Reports
    • Corporate governance
    • Share information
    • Investor Relations
  • Contact
  • Share price:
  • Latest: (SEK)  
  • High: (SEK)  
  • Nasdaq
  • Toleranzia - Twitter

News

  • All press releases
  • Events
  • Media

Press releases

3 May - 2023

Toleranzia AB: Interim report 2023-01-01 – 2023-03-31

First quarter, 2023 Three months, January 1 – March 31·         Net sales amounted to — KSEK...

6 May - 2022

Toleranzia AB: Interim Report 2022-01-01 – 2022-03-31

First quarter 2022 First quarter, 1 January – 31 March·         Net sales 0 SEK (0 SEK).·        ...

Subscribe to
Toleranzia’s news here

Toleranzia AB

Arvid Wallgrens backe 20, 8th floor
SE-413 46 Göteborg, Sweden

More contact info

© 2015-2023 Toleranzia AB | All rights reserved

plucera webbyrå

  • Start
  • About us
    ▼
    • Operations
    • Board of Directors
    • Management
    • Team
    • Collaboration
    • Career
  • Technology
    ▼
    • Tolerogens
  • Program
    ▼
    • Autoimmune disease
    • Rare disease
    • Myasthenia Gravis
    • SME Instrument
    • Pipeline
  • News
    ▼
    • All press releases
    • Events
    • Media
  • Investors
    ▼
    • Rights Issue 2023
    • Reports
    • Corporate governance
    • Share information
    • Investor Relations
  • Contact